Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here: https://xitter.cf/t.co/CBx3GZBv31
Joined July 2015
- Tweets89.4K
- Following4.7K
- Followers165K
- Likes45K
Pinned Tweet
This year, as in past years, we’ve found inspiring stories and innovative research. All are blazing new trails as they attempt to answer some of the biggest questions in science and medicine.
Meet the 2026 #STATWunderkinds!
statnews.com/wunderkinds/
CMS is cracking down on adult day cares in New York, part of a broader focus on alleged health care frauds. trib.al/TkAkRGr
"How knocking on doors can help beat measles — again. America pushed back on diseases by building trust door by door. Let’s go back to that model." statnews.com/2026/10/21/meas…
An endocrinologist who had long served in the American Diabetes Association's leadership is out without explanation. trib.al/DxPwD6B
Meet STAT Wunderkind Nandini Raghuraman from the University of Maryland School of Nursing. She is studying how pain is molded by our environment.
Read more about her work: statnews.com/wunderkinds/nan…
#STATWunderkinds
ALT This is an image featuring a person with long hair and glasses, smiling. They are identified as Nandini Raghuraman from the University of Maryland School of Nursing. The image has a green background with a faint collage of faces and the text "STAT Wunderkinds '26.
In this edition of STAT's AI Prognosis: What does Isomorphic Labs' high valuation say about AI's role in drug development, and the debate around AI and cost of care. trib.al/6zOOdrM
Meet STAT Wunderkind Mohamed El-Brolosy, who's unraveling how organisms cope with disruptions in their DNA.
Read more about his work: bit.ly/3VVM93v
#STATWunderkinds
ALT A person smiling in front of a teal background with faded portraits. Text reads: "STAT Wunderkinds '26. Mohamed El-Brolosy, Harvard Society of Fellows.
STAT retweeted
Housekeeping note: I'm flying to Madrid tonight to cover #ESMO26, joined by my colleague @DrewQJoseph
We'll have stories + our ESMO pop-up newsletter. If you want to receive the latter (it's free) you can sign up here:
statnews.com/signup/esmo-30-…
STAT retweeted
Mark Cuban wants to crack open the market for rare disease treatments statnews.com/2026/10/21/mark… via @statnews
A counterintuitive way to build trust in measles vaccines and public health. Acknowledging that most children recover could build credibility, experts say. statnews.com/2026/10/21/meas…
Exclusive: Mark Cuban wants to crack open the market for rare disease treatments trib.al/iNiy55i
GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous methods. trib.al/yQ7jwoh
GSK has won FDA approval for its hepatitis B drug, which will be marketed as Hibsago.
The approval for the drug covers select adults with chronic hep B infections, a leading cause of liver cancer and cirrhosis and which kill 1 million people a year. trib.al/uEcNtm7
Mark Cuban has a new vision for his company Cost Plus Drugs: shake up the business of custom-made rare disease medicines trib.al/kF7qUSb
Nigeria has confirmed an imported Ebola case tied to the ongoing outbreak centered in the Democratic Republic of the Congo, becoming the fifth country to identify a related infection, health… trib.al/ywwathc
An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye disease non-infectious uveitis. trib.al/7Kd1g7l
Nigeria confirmed an Ebola case tied to the ongoing outbreak centered in the DRC, health officials said.
In recent weeks, Kenya has documented nine cases tied to an imported infection, as the outbreak — the second largest on record — continues to grow. trib.al/7MGEko5
Some experts say public health messaging would be more credible if it focused less on measles deaths and acknowledged that most children survive. trib.al/4qf6e0v
“Committing a Type 1 error does not reflect poorly on the quality of the science done,” writes Mark Louie F. Ramos trib.al/SJh4uMg
After a quarter century of work, the German biotech Immatics is facing a pivotal moment as it awaits Phase 3 results for its lead candidate in melanoma. trib.al/YoNUC1X
“As measles outbreaks spread in the U.S., it may be time to learn how other countries get their outbreaks under control,” writes Raj Panjabi. trib.al/yDenWh3